“ The general director of Actavis Poland talks about competing in an intense generics market, and the company's potential in Poland given the country's 2012 Reimbursement Act. ”
In Conversation
“ AstraZeneca’s General Manager in Poland discuses AstraZeneca’s strategic realignment to become a highly specialized biotech company after 20 years of presence in Poland. He stresses the… ”
“ “70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, ”
“ Rodrigo Azócar Ibaceta, general manager at ”
“ Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. ”
“ Emilio Lora-Tamayo, president of the Spanish National Research Council (CSIC), outlines Spain’s current strengths and weaknesses in the areas of research and innovation. ”
“ Despite a number of setbacks in public funding as a result of Spain’s recession, the Spanish National Biotechnology Center (CNB) has continued to remain at the… ”
“ Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. ”
“ Novascon Pharmaceuticals is the second fastest growing company in the OTC/dietary supplement market in Poland. Its founder shares the reasons behind this success, including his strategy… ”
“ Omega Pharma is a pharmacist champion and one of the fastest growing OTC companies in Poland. Its General Manager in Poland discusses the shift taking place… ”
“ Schulke Poland’s General Manager wants the affiliate: “to be recognized as a high quality “one stop shop” for hygiene and disinfection. He also comments: “Poland is… ”
“ Eduardo Sanchiz took over as CEO of Spain’s flagship pharmaceutical company Almirall in 2011, after Jorge Gallardo stepped down in this role while staying as Chairman… ”
